The global drug discovery informatics market is projected to grow at a CAGR of 11.2%

Wednesday, January 10, 2018 Drug News
Email Print This Page Comment bookmark
Font : A-A+

The global drug discovery informatics market is projected to grow at a CAGR of 11.2%.

LONDON, Jan. 9, 2018 /PRNewswire/ -- Download the full report: https://www.reportbuyer.com/product/5273232 The

global drug discovery informatics market is expected to reach USD 2.84 billion in 2022 from USD 1.67 billion in 2017 at a CAGR of 11.2%. Growth in the drug discovery informatics market is mainly driven by factors such as rising R&D expenditure across the globe, increasing focus on drug delivery, and the need to control drug discovery and development costs. Impending patent expiries and the growing biotechnology industry are also expected to provide a wide range of growth opportunities for players in the market. On the other hand, the scarcity of skilled professionals and the high pricing and setup cost of informatics software are both factors that are expected to limit market growth to a certain extent. The sequencing and target data analysis segment is expected to account for the largest share in 2017. On the basis of function, the drug discovery informatics market is divided into sequencing and target data analysis, docking, molecular modeling, libraries & database preparation, and other functions. In 2017, the sequencing and target data analysis segment is expected to account for the largest share of the drug discovery informatics market. Factors such as the expansive application of informatics solutions in targeted analysis and the large amount of data generated during the drug discovery process are driving the growth of this segment. The software segment is expected to account for the largest share in 2017. On the basis of solution, the market is classified into software and services. In 2017, the software segment is expected to account for the largest share of the global drug discovery informatics market. The largest share of this segment is attributed to the fast and efficient management of data generated throughout the drug discovery process using discovery informatics software solutions North America is expected to account for the largest share during the forecast period. By geography, North America is expected to account for the largest share of the drug discovery informatics market in 2017. Established pharmaceutical industry with the presence of leading pharmaceutical and biotechnology companies attributes to the largest share of North America. Europe is expected to account for the second-largest share of the drug discovery informatics market. Break-up profile of primaries: • By Company Type- Tier 1-45%, Tier 2-34% and Tier 3-21% • By Designation-C-level-36%, D-level-40% and Others-24% • By Region-North America-40%, Europe-22%, Asia Pacific-30%, and RoW-8% The key players operating in the drug discovery informatics market are IBM (US), Infosys (India), Schrodinger (US), PerkinElmer (US), and Thermo Fisher Scientific (US). Research Coverage: The drug discovery informatics market in this report is segmented by function, solution, end user, and region. The study tracks and analyzes competitive developments such as product launches, collaborations, agreements, partnerships, and acquisitions, and profiles key players and core competencies in the drug discovery informatics market. Reasons to buy this report: The report provides insights on the following pointers: • Market Penetration: Comprehensive information on portfolios offered by the top players in the global drug discovery informatics market. The report analyzes the market by function, solution, end user, and region • Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and product launches in the global drug discovery informatics market • Market Development: Comprehensive information about lucrative emerging markets—the report analyzes the markets for global discovery informatics products across regions • Market Diversification: Exhaustive information about new products, untapped geographies, and recent developments in the global drug discovery informatics market • Competitive Assessment: In-depth assessment of strategies, products, and manufacturing capabilities of the key players in the global drug discovery informatics marketDownload the full report: https://www.reportbuyer.com/product/5273232 About Reportbuyer Reportbuyer is a leading industry intelligence solution that provides all market research reports from top publishers For more information: Sarah Smith Research Advisor at Reportbuyer.com Email: sarah@reportbuyer.com  Tel: +1 (646) 453 6293 Website: www.reportbuyer.com  

Cision View original content:http://www.prnewswire.com/news-releases/the-global-drug-discovery-informatics-market-is-projected-to-grow-at-a-cagr-of-112-300580357.html

SOURCE ReportBuyer

Advertisement


Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store